Alberta’s first death is related to the AstraZeneca vaccine, the second in Canada


EDMONTON – A woman has died in her 50s from rare complications associated with receiving the COVID-19 AstraZenecic vaccine.

This marks the second case of vaccine-induced thrombotic thrombocytopenia (VITT) in Canada and the only AstraZeneca vaccine-related death in Alberta.

A 54-year-old woman died of VITT on 27 April in Quebec.

Dr. Dina Hinshaw reported the death in a tweet on Tuesday evening. He said that no further case information will be given regarding patient confidentiality.

According to Hinshaw, 253,000 doses of AstraZeneca or CoviShield have been administered in the province to date.

“My apologies for sharing this sad news for so long, but we promised to alert Alberts as soon as possible in such confirmed instances,” she said.

The top doctor in Alberta reminded people that the risk of getting death or other serious consequences from a vaccine is extremely rare.

According to Alberta Health Services, the global frequency of VITT has been estimated in approximately one case at 100,000 to 250,000 doses of the vaccine.

Albert, aged 50 to 59, who has been diagnosed with COVID-19, is 350 times more likely to die from the disease after experiencing fatal complications after receiving the AstraZeneca vaccine.

.

Latest articles

Related articles